Stable Isotope Labeling Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC 157 in Doping Control by UHPLC HRMS BPC 157: What a Psychiatrist Wants You to Know Dr. Baghel BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BPC 157 has already hit the mainstream, but should it hit your bloodstream?